2016
DOI: 10.1210/jc.2016-2481
|View full text |Cite
|
Sign up to set email alerts
|

Thiazide Treatment in Primary Hyperparathyroidism—A New Indication for an Old Medication?

Abstract: Thiazides may be effective even at a dose of 12.5 mg/d and safe at doses of up to 50 mg/d for controlling hypercalciuria in patients with PHPT and may have an advantage in decreasing serum parathyroid hormone level. However, careful monitoring for hypercalcemia is required.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
7
0
2

Year Published

2017
2017
2024
2024

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 32 publications
(11 citation statements)
references
References 18 publications
0
7
0
2
Order By: Relevance
“…If thiazides do have a significant impact on plasma calcium we would have expected to see greater reduction in calcium at 1 year after their cessation in our non-surgical patients on thiazide diuretics at diagnosis (thiazides were discontinued in all patients in this cohort). However, no significant difference was observed lending further evidence to the contention ( 9 ) that the diagnosis of PHPT should not lead to automatic discontinuation of thiazides.…”
Section: Discussionmentioning
confidence: 73%
See 1 more Smart Citation
“…If thiazides do have a significant impact on plasma calcium we would have expected to see greater reduction in calcium at 1 year after their cessation in our non-surgical patients on thiazide diuretics at diagnosis (thiazides were discontinued in all patients in this cohort). However, no significant difference was observed lending further evidence to the contention ( 9 ) that the diagnosis of PHPT should not lead to automatic discontinuation of thiazides.…”
Section: Discussionmentioning
confidence: 73%
“…The initial recommended screening test to exclude FHH, in addition to a full family history, is the urine calcium creatinine clearance ratio (CCCR), which should be >0.01 in patients with PHPT ( 8 ). Another potential contributor to hypercalcaemia in patients with probable PHPT is thiazide diuretic use, although recent reports suggest the impact to be minimal and paradoxically thiazides may even reduce blood PTH concentrations ( 9 ).…”
Section: Introductionmentioning
confidence: 99%
“…In principle, thiazide diuretics, i.e., those most commonly used in hypertension, alone or in combination with other pharmacological classes (ACE inhibitors, angiotensin receptor blockers, and beta-blockers) are regarded not to usually increase, but rather decrease renal excretion of calcium ions [29]. Hence their participation in bone mineral depletion processes should be deemed to occur less likely when compared to that attributed to the loop diuretics (furosemide, torsemide, and etacrinic acid) .…”
Section: Discussionmentioning
confidence: 99%
“…In principle, thiazide diuretics, i.e., those most commonly used in hypertension, alone or in combination with other pharmacological classes (ACE inhibitors, angiotensin receptor blockers, beta-blockers) are regarded not to usually increase, but rather decrease renal excretion of calcium ions ( 28 ). Hence their participation in bone mineral depletion processes should be deemed to occur less likely when compared to that attributed to the loop diuretics (furosemide, torsemide, etacrinic acid).…”
Section: Discussionmentioning
confidence: 99%